AwardedCroatiaGoods€374,992
NABAVA LIJEKA OKRELIZUMABA
- Published
- Published 17 June 2026
Overview
Klinički bolnički centar Osijek procured the drug ocrelizumab 920 mg for a one-year period. The contract was awarded to ROCHE d.o.o. on 11 May 2026 for EUR 374,999.20.
Key details
- Country
- Croatia
- Status
- Awarded
- Category
- Goods
- Estimated value
- €374,992
- Procedure
- Direct
- Published
- 17 June 2026
Various medicinal products
Award outcome
- Awarded value
- €374,999
- Award date
- 11 May 2026
- ROCHE d.o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 June 2026
Contracting authority
Klinički bolnički centar Osijek
Procuring entityOsijek, Croatia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.